Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review

As the clinical applications of immune checkpoint inhibitors (ICIs) expand, our knowledge of the potential adverse effects of these drugs continues to broaden. Emerging evidence supports the association between ICI therapy with accelerated atherosclerosis and atherosclerotic cardiovascular (CV) even...

Descripción completa

Detalles Bibliográficos
Autores principales: Suero-Abreu, Giselle Alexandra, Zanni, Markella V., Neilan, Tomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830225/
https://www.ncbi.nlm.nih.gov/pubmed/36636438
http://dx.doi.org/10.1016/j.jaccao.2022.11.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830225/
https://www.ncbi.nlm.nih.gov/pubmed/36636438
http://dx.doi.org/10.1016/j.jaccao.2022.11.011

Ejemplares similares